Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07316374

AI Chatbots for Anxiety Mental Health Literacy

Evaluation of AI-Based Chatbots for Improving Anxiety-Related Mental Health Literacy: A Randomized Controlled Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Peking University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to examine whether AI-based chatbots can improve anxiety-related mental health literacy in adults with varying levels of anxiety. The study aims to learn whether interactive AI chatbots can improve understanding of anxiety, attitudes toward anxiety, help-seeking intentions, confidence in supporting others, and anxiety symptoms, compared with standard text-based educational materials. The main questions it aims to answer are: 1. Does an AI-based psychoeducation chatbot improve anxiety-related mental health literacy compared with text-based psychoeducation? 2. Does adding interactive anxiety simulation conversations further improve mental health literacy and related outcomes compared with psychoeducation alone? Researchers will compare participants who use an AI psychoeducation chatbot alone, participants who use an AI psychoeducation chatbot combined with anxiety simulation chatbots, and participants who receive text-based psychoeducation, to see whether the AI-based interventions lead to greater improvements in mental health literacy and related outcomes. Participants will: 1. Complete baseline questionnaires assessing anxiety-related knowledge, attitudes, and symptoms 2. Be randomly assigned to one of three groups: AI psychoeducation chatbot, AI psychoeducation chatbot plus anxiety simulation chatbots, or text-based psychoeducation 3. Use the assigned intervention over a one-week period 4. Complete follow-up questionnaires immediately after the intervention and at later follow-up time points

Conditions

Interventions

TypeNameDescription
BEHAVIORALAI Anxiety Literacy EducationAI Anxiety Literacy Education is an AI-powered, psychologically informed chatbot designed to improve mental health literacy related to anxiety through conversational education. The chatbot delivers structured modules covering the definition of anxiety, common cognitive, emotional, physical, and behavioral symptoms, contributing factors, treatment options, and practical self-help strategies. Content is presented in non-clinical language and adapted to user responses through guided questions and feedback, encouraging users to reflect on their own experiences.
BEHAVIORALAI Anxiety Friend SimulationAI Anxiety Friend Simulation is an AI-powered conversational intervention designed to allow participants to practice recognizing and responding to anxiety-related experiences in a simulated interaction. The chatbot role-plays individuals experiencing different anxiety presentations and communicates in a natural, everyday manner that may include uncertainty, emotional reactions, or defensiveness. Participants are guided to identify anxiety symptoms, explore causes, and propose supportive responses. The chatbot provides feedback and prompts reflection based on participants' responses. Participants access the simulation online and complete multiple simulated conversations over a one-week period.
BEHAVIORALText-Based Anxiety PsychoeducationText-Based Anxiety Psychoeducation consists of written educational materials providing information about anxiety in a non-clinical, accessible format. The materials cover the definition of anxiety, common cognitive, emotional, physical, and behavioral symptoms, contributing factors, and general coping and self-help strategies. Participants access the materials online and are instructed to review all content within a one-week period. The materials are static and do not provide interactive feedback or personalized responses.

Timeline

Start date
2025-12-01
Primary completion
2026-02-01
Completion
2026-04-30
First posted
2026-01-05
Last updated
2026-01-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07316374. Inclusion in this directory is not an endorsement.